A Phase II Multicenter Study to Explore the Efficacy and Safety of Brostallicin in Patients With Myxoid Liposarcoma With (12:16) Translocation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2014
At a glance
- Drugs Brostallicin (Primary)
- Indications Liposarcoma
- Focus Therapeutic Use
- Sponsors Systems Medicine
- 03 Mar 2010 Planned end date changed from 1 Apr 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 24 Feb 2009 Fred Oldham added as a lead investigator, as reported by ClinicalTrials.gov.
- 30 Sep 2008 Checked against clinicaltrials.gov record: added official title and end points.